financetom
Business
financetom
/
Business
/
Micron Technology's Bullish AI-Driven Outlook, Strong Fourth-Quarter Financials Quiet Negativity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Micron Technology's Bullish AI-Driven Outlook, Strong Fourth-Quarter Financials Quiet Negativity
Oct 3, 2024 1:47 AM

03:27 PM EDT, 09/26/2024 (MT Newswires) -- Micron Technology's ( MU ) bullish outlook for the new fiscal year, combined with its strong fiscal fourth-quarter earnings, upended negative sentiment heading into its late-Wednesday earnings release.

Fueled by robust artificial intelligence demand, particularly in the data center space, Micron now sees the market for its high-bandwidth memory, or HBM, products eclipsing $25 billion in the 2025 calendar year, up from an addressable market of $4 billion in 2023 and above previous guidance of $20 billion for next year, executives said late Wednesday on the company's earnings call. HBM is now forecast to be around 6% of overall industry dynamic random access memory bits in 2025, up from 1.5% in 2023.

Strong HBM demand has helped drive interest in the company's data center portfolio, Brian Chin, an equity research analyst at Stifel, told MT Newswires. That's more than offset concerns of softness in its consumer segments, namely PCs and phones, which have been beset by high inventory levels, a trend that's expected to continue.

"One of the fear factors in the cycle was that HBM will move into oversupply next year," Chin said. "They gave no indication they have concern or there is any change in expecting a ramp up in business next year. There's a lot of comfort in that."

Shares were up 15% in Thursday afternoon trading.

Morgan Stanley analyst Joseph Moore said in a note that he's not worried about HBM oversupply, calling it a "design win business, not a gross margin inflated by shortage." Still, he parted with optimists with respect to non-data center supply and demand dynamics.

"The dynamics of excess inventory everywhere -- PC and smartphone (original equipment manufacturers), memory producers, even some of our cloud contacts amid very strong demand -- are OK until they aren't," Moore said. "We saw this dynamic in 2021, when everyone was ignoring inventories climbing in every market until it suddenly mattered for pricing. We aren't seeing that oversupply impact pricing yet, but it seems dangerous to ignore it."

The strong operational outlook fed into a positive forecast for financials, with Micron projecting gross margin expansion and low double-digit revenue growth sequentially for the first quarter of fiscal 2025 even as the consumer segment is expected to continue working through its inventories.

"Overall memory dynamics are likely to improve significantly post (the first quarter of calendar 2025) following the normalization of inventories at client device OEMs," Wedbush analyst Matt Bryson said in a note to clients.

Micron reported fiscal fourth-quarter non-GAAP earnings late Wednesday of $1.18 per share, up from a loss of $1.07 a year earlier and above the Capital IQ consensus of $1.11 per share. Revenue for the quarter was $7.75 billion, up from $4.01 billion in the year-ago period and above the consensus estimate of $7.65 billion.

"We are exiting the fiscal year with excellent momentum, having expanded our industry-leading product portfolio, executed well on pricing, and improved our financial performance significantly from the start of the year," Micron Chief Financial Officer Mark Murphy said on the earnings conference call.

Price: 110.99, Change: +15.22, Percent Change: +15.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Norway's Disagreement With US Over Caterpillar Divestment is Easing
Market Chatter: Norway's Disagreement With US Over Caterpillar Divestment is Easing
Sep 25, 2025
11:10 AM EDT, 09/25/2025 (MT Newswires) -- Tensions with the US over Norway's sovereign wealth fund's divestment from Caterpillar ( CAT ) appear to be easing, Reuters reported Thursday, citing Norway's Foreign Minister Espen Barth Eide. The $2 trillion fund decided in August to divest from Caterpillar ( CAT ), citing the company's supply of bulldozers used by Israeli authorities...
Instagram's teen safety features are flawed, researchers say
Instagram's teen safety features are flawed, researchers say
Sep 25, 2025
(Reuters) -Numerous safety features that Meta has said it has implemented to protect young users on Instagram over the years do not work well or, in some cases, don't exist, according to a report from child-safety advocacy groups that was corroborated by researchers at Northeastern University. The study, which Meta disputed as misleading, comes amid renewed pressure on tech companies...
GCEX Group Acquires GlobalBlock to Accelerate Growth Amongst Wealth & Asset Managers
GCEX Group Acquires GlobalBlock to Accelerate Growth Amongst Wealth & Asset Managers
Sep 25, 2025
London, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Leading regulated digital prime broker GCEX (GCEX Group) has acquired GlobalBlock Europe, a specialist crypto brokerage and asset management firm focused on high-net-worth individuals (HNWI) with over $60 million in client assets.  This strategic transaction marks a natural expansion for GCEX from its established OTC, conversion and technology business into a broader digital assets proposition for asset...
Capricor Therapeutics Shares Rise After FDA Aligns on Endpoints for DMD Therapy Trial
Capricor Therapeutics Shares Rise After FDA Aligns on Endpoints for DMD Therapy Trial
Sep 25, 2025
11:12 AM EDT, 09/25/2025 (MT Newswires) -- Capricor Therapeutics ( CAPR ) shares were up 5% in recent Thursday trading after it reported a regulatory update on its biologics license application for deramiocel, its investigational Duchenne muscular dystrophy therapy, following a recent Food and Drug Administration Type A meeting. The regulator said that it and Capricor are aligned on endpoints...
Copyright 2023-2026 - www.financetom.com All Rights Reserved